The European Medicines Agency (EMA) is advancing regulatory processes with the recent release of eCTD EU Module 1 Specification V3.1, Validation Criteria V7.1, and updates to accepted file formats. This marks another important stride towards harmonization and modernization. The Human Harmonisation Group (HHG), a key body within the EMA, has reviewed the change requests by stakeholders for the eCTD EU Module 1 Specification, resulting in three vital documents now open for public consultation:
Proposed Changes in eCTD EU Module 1 Specification:
In general, the HHG aims in its amendments to enhance clarity, security, and efficiency in the submission process.
Appendix 1 has been updated as follows:
In Appendix 2, specific clarifications have been introduced:
3. Changes in EU Accepted File Formats:
The effective date for these changes will be announced upon publication, allowing a transition period of nine months for implementation.
Stakeholders are encouraged to actively participate in the public consultation, with the deadline for submitting questions and responses set for 12 January 2024 via email at EUM1Spec@ema.europa.eu.
Are you also interested in regular updates on US FDA and Health Canada regulations? Subscribe to our newsletter and never miss an update again: https://www.extedo.com/regulatory-newsletter-usa-canada-subscribe
If you have any questions or need support regarding your submissions to EMA, we are happy to help - find out more about our Regulatory Publishing Services offer or get in contact: info@extedo.com.